Gates is Still Gunning for HIV. Here’s the Latest
Gates has been backing HIV self-testing and rapid diagnostics projects since around 2010, when it invested $600,000 in Daktari Diagnostics, a company focused on “delivering critical diagnostic test results.” In 2015, Daktari rolled out its portable point-of-care device that measures CD4 cell counts. CD4s are white blood cells that fight infection and are defined as “antigen[s] found on helper T cells.” The following year, in 2011, Gates awarded PATH a $1.1 million grant to “develop a target product profile for a future HIV self-test.” Read more >>